Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03191474 · ClinicalTrials.gov registry record · NA
Linkage of Transgender Individuals to PrEP
A NA study of HIV Seronegativity and Linkage, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 202
- Enrollment target
- 2
- Study locations
NCT03191474 is a NA study of HIV Seronegativity and Linkage that has completed, run by University of California, San Diego. The registered enrollment target is 202 participants, above the 109-participant average among 3 other HIV Seronegativity trials with a reported enrollment target (85% higher). The trial reports 2 study locations across 1 state.
The verdict
NCT03191474, a NA study of HIV Seronegativity and Linkage, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 202 participants
- Enrollment target
- 2
- Study locations
Study Summary
CCTG 602 is a multisite demonstration project to evaluate the effectiveness of facilitated linkage to PrEP using a community-based transgender PrEP outreach worker (T-POWr) versus standard of care (SOC).
Conditions Studied
Interventions
- BEHAVIORAL T-POWr Intervention
Study Locations (2)
California
- Los Angeles Lesbian, Gay, Bisexual, and Transgender Center - Los Angeles
- UC San Diego AntiViral Research Center (AVRC) - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 202 participants |
| Start Date | 2017-07-28 |
| Est. Completion | 2020-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03191474
The ClinicalTrials.gov registry entry for NCT03191474 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 202 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 109-participant average among 3 other HIV Seronegativity trials with a reported enrollment target (85% higher). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with HIV Seronegativity appearing as the primary indexed condition, and to 1 intervention - of which T-POWr Intervention is the first listed.
NCT03191474 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03191474 about?
NCT03191474 is a clinical study titled "Linkage of Transgender Individuals to PrEP". CCTG 602 is a multisite demonstration project to evaluate the effectiveness of facilitated linkage to PrEP using a community-based transgender PrEP outreach worker (T-POWr) versus standard of care (SOC).
What is the current status of trial NCT03191474?
This trial is currently completed. It is a NA study. The enrollment target is 202 participants. The study started on 2017-07-28. Estimated completion is 2020-03-31.
What conditions does trial NCT03191474 study?
This clinical trial studies the following conditions: HIV Seronegativity, Linkage.
What interventions are being tested in trial NCT03191474?
The interventions under investigation include: T-POWr Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03191474?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03191474 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Seronegativity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.